Mutations to the canonical ϩ1G of introns, which are commonly found in many human inherited disease alleles, invariably result in aberrant splicing. Here we report genetic findings in C. elegans that aberrant splicing due to ϩ1G mutations can be suppressed by U1 snRNA mutations. An intronic ϩ1G-to-U mutation, e936, in the C. elegans unc-73 gene causes aberrant splicing and loss of gene function. We previously showed that mutation of the sup-39 gene promotes splicing at the mutant splice donor in e936 mutants. We demonstrate here that sup-39 is a U1 snRNA gene; suppressor mutations in sup-39 are compensatory substitutions in the 5Ј end, which enhance recognition of the mutant splice donor. sup-6 (st19) is an allele-specific suppressor of unc-13(e309), which contains an intronic ϩ1G-to-A transition. The e309 mutation activates a cryptic splice site, and sup-6(st19) restores splicing to the mutant splice donor. sup-6 also encodes a U1 snRNA and the mutant contains a compensatory substitution at its 5Ј end. This is the first demonstration that U1 snRNAs can act to suppress the effects of mutations to the invariant ϩ1G of introns. These findings are suggestive of a potential treatment of certain alleles of inherited human genetic diseases.
T HE splice donor consensus sequence undergoes
Siliciano and Guthrie 1988; Cohen et al. 1993; Lo et al. 1994) . U1 snRNA suppressors were developed to base-pairing interactions with the 5Ј end of U1 sn-RNA early in spliceosome assembly (Ares and Weiser suppress mutations that occur at the Ϫ1, ϩ3, ϩ5, and ϩ6 positions of the 5Ј splice site, positions that vary 1994). Mutations to the canonical G that begins all intron substrates of the major spliceosome (the ϩ1G) naturally in metazoans. Studies in yeast and mammalian cells indicated that mutations to the ϩ1G could not be lead to loss of splicing to the wild-type site and often to activation of nearby cryptic splice sites. The cryptic splice suppressed by compensatory mutations in U1 snRNA (Siliciano and Guthrie 1988; Cohen et al. 1994) . It sites resemble splice donor consensus sequences but have weaker homology to the consensus than the origihas been proposed that the ϩ1G has additional essential functions in the splicing mechanism through interacnal splice donor (Roca et al. 2003) . Early studies estimated that at least 15% of point mutations responsible tions with the terminal nucleotide of the intron and by for human genetic diseases disrupt signals involved in binding to PRP8 and U6 snRNA (Parker and Siliciano splicing (Krawczak et al. 1992) , and these often disrupt 1993; Reyes et al. 1996 Reyes et al. , 1999 . The PRP8 protein of the the ϩ1G. This may be an underestimate as extensive U5 snRNP, as a component of the U4/U6•U5 tri-snRNP, analysis of disease alleles of neurofibromatosis type 1 interacts with this nucleotide early in spliceosome asand ataxia telangiectasia indicate that 50% of alleles sembly in an ATP-dependent manner, perhaps at the surveyed affect pre-mRNA splicing (Teraoka et al. 1999;  same time as U1 snRNA or as part of the transition from Ars et al. 2000) .
U1 to U6 interactions (Maroney et al. 2000) . Reverse genetic approaches in mammalian cells, Dro- In a previous article we analyzed the mechanism of sophila, and yeast have shown that mutant U1 snRNAs suppression of splicing defects in unc-73(e936) by mutawith compensatory substitutions in their 5Ј ends can tions in sup-39 (Roller et al. 2000) . The e936 mutation suppress the effects of mutations to splice donor consenchanges the ϩ1G of intron 15 to U (Steven et al. 1998) . sus sequences to promote splicing at a mutated donor sup-39 was identified as an allele-specific suppressor of site (Zhuang and Weiner 1986; Zhuang et al. 1987;  the uncoordination defect of unc-73(e936) (Run et al. 1996) . Therefore we reasoned that an allele-specific suppressor of a splice-site defect might function at the level firmed through the analysis of splicing of the green fluorescent frame. The third splice donor, used in 10% of steadyprotein (GFP)-lacZ-unc-73(e936) splicing reporter fusion constate e936 messages, is the mutated splice donor at the struct azEx1 (Roller et al. 2000) . To construct animals conwild-type position. Use of this splice site defines an intaining the recombinant LGII and azEx1, N2 males were tron beginning with UU. This was surprising to find crossed to the animals containing recombinant LGII. F 1 males from this cross were then crossed to strain SZ4 containing because previous work had suggested that mutations to azEx1. F 2 animals from this cross homozygous for the recombithe ϩ1 position of the intron would result, at best, in nant chromosome were selected and these were screened for the first step of splicing but not the second transesterifthe roller phenotype of azEx1 or the GFP phenotype of this cation reaction (Newman et al. 1985 ; Parker and Gutharray. Animals containing these markers were then grown up rie 1985). In the presence of a sup-39 mutation, these on a large plate and RNA was extracted from the animals as same three splice donors are used, but the ratio of previously described (Roller et al. 2000) . The splicing of the azEx1 reporter construct was assayed using the 32 P reverse messages produced by splicing at these sites changes.
transcription-polymerase chain reaction assay as described
The percentage of unc-73(e936) messages containing the previously (Roller et al. 2000) .
wild-type splice junction is increased to 33% with a corre-
The position of the chromosomal crossover event in each sponding increase in the level of UNC-73 protein (sumof the recombinant chromosomes was determined through marized in Figure 1A ). We did many controls to demonanalysis of single nucleotide polymorphisms (SNPs) that lead to restriction fragment length polymorphisms between the strate that this effect is due to changes in splicing and CB4856 and N2 strains, as described by Wicks et al. (2001) not to differential changes in message stability. This sup- 
Caenorhabditis elegans genome. Both known alleles pos-
Identification of sup-39 : We cloned and sequenced a U1 snRNA gene located in the intron of the gene C15F1.5 to sess the same mutation, which is a compensatory substidetermine if this had a lesion in it consistent with it being tution in the 5Ј end of this U1 snRNA to match the sup-39(je5) . We used the primers 5Ј-aggaattcctccatcgtcgtcatc-3Ј ϩ1G-to-U mutant splice donor in e936. We have also and 5Ј-cagaattctaacggtaggtgtactggag-3Ј to amplify the entirety identified another U1 snRNA gene as a dominant supof the 900-base sixth intron of C15F1.5 containing the U1 pressor of a 5Ј splice-site mutation. sup-6 is an allelesnRNA coding region. The primers had EcoRI restriction sites built into them so that the PCR products of the amplification specific suppressor of a mutation in unc-13(e309), which reaction were then cloned into the EcoRI site of pBluescript changes the first nucleotide of an intron from G to A. KSϩ (Stratagene, La Jolla, CA) . This region was amplified
The sup-6 mutation alters the 5Ј end of U1 so that it is and cloned from N2, sup-39(je5), and sup-39(je6) animals and complementary to the mutation in the 5Ј splice site. the inserts were sequenced on both strands using the M13 These are the first examples in any organism of suppresforward and reverse primers.
RT-PCR assays for unc-13(e309) splicing: To detect changes sors of mutations to the ϩ1 position of the intron that to splicing induced by the ϩ1G-to-A mutation in e309, RT- activate complete splicing at the proper site. These may PCR reactions were used. Total RNA from was extracted from a have important implications for treatment of specific large plate of N2, unc-13(e309);dpy-10(e128) , and unc-13(e309)I; alleles of human genetic diseases.
dpy-10(e128)sup-6(st19)/dpy-10(e128) sup-6(ϩ)II animals using methods previously described (Roller et al. 2000) . RNA was reverse transcribed with a primer specific for exon 20, 5Ј-tga caagactgcaggtactc-3Ј, and then PCR reactions were done using MATERIALS AND METHODS the RT primer and a 32 P 5Ј end-labeled primer that annealed to exon 17 5Ј-tgctgctcattgtgtagatg-3Ј. PCR products were sepaStrains used: All C. elegans strains used in this study, with the exception of SZ4, were obtained from the Caenorhabditis rated on a 6% polyacrylamide urea gel and visualized by autoradiography. To determine the sites of cryptic splice donor Genetics Center at the University of Minnesota.
Mapping of sup-39: sup-39 was reported to map to position usage, RT-PCR reactions were performed as above except that an EcoRI site was added to the 5Ј end of the 5Ј PCR primer ϩ0.22 Ϯ 0.056 cM of LGII (Run et al. 1996) . To precisely map the location of sup-39, single nucleotide polymorphisms and a BamHI site was added to the 3Ј end of the 3Ј PCR primer. These PCR products were cloned into pBluescript between CB4856 and the Bristol N2 strain were used to identify regions of chromosomal crossovers. Strain JW104 (Run et al. KSϩ (Stratagene) . Products from unc-13(e309);dpy-10(e128) and unc-13(e309)I; dpy-10(e128) sup-6(st19)/dpy-10(e128) sup-6 1996) has the genotype dpy-10(e128) sup-39(je5) unc-4(e120) II. CB4856 males were crossed to JW104 hermaphrodites. F 2 (ϩ)II animals were sequenced. Identification of sup-6 : The C. elegans gene F58G1.7 contains animals that were either Dpy non-Unc or Unc non-Dpy were selected and lines homozygous for the recombinant chromoa U1 snRNA gene located in its fifth intron, and its map position is predicted to be very close to the map position of somes were recovered. A total of 50 Dpy non-Unc and 50 Unc non-Dpy strains were obtained. These were tested for the sup-6. We cloned and sequenced this gene using the primers 5Ј-aggaattcacacacgcgagcactagtc-3Ј and 5Ј-cgaggatccgtaacacctg presence of sup-39(je5) by the ability to suppress unc-73(e936) using crosses described previously (Run et al. 1996) . In addicgatgaattgc-3Ј to generate a 280-base-long PCR product containing this U1 snRNA gene. The primers had EcoR1 and tion, in selected strains the presence of sup-39(je5) was con-U1 snRNA Suppressors in C. elegans BamH1 restriction sites built into them and the products were embryos. st19 heterozygotes are morphologically and cloned into these sites in pBluescript KSϩ (Stratagene). This behaviorally indistinguishable from wild-type animals. product was amplified from the strain CB2987 in which wildTo determine whether sup-6(st19) acts at the level of type moving animals are heterozygous for the sup-6(st19).
the splicing of the e309 message, we isolated RNA from Twelve cloned inserts from this amplification were sequenced. Four had the wild-type gene sequence and 8 of the inserts cultures of wild-type, unc-13(e309), and unc-13(e309);sup-6 contained a point mutation near the 5Ј end of this U1 snRNA (st19)/sup-6(ϩ) animals. Reverse-transcription-PCR analgene, consistent with the fact that these clones were derived ysis of unc-13 messages from these strains is shown in from heterozygous sup-6(st19)/ϩ animals. Figure 2B . In the presence of the unc-13(e309) mutation, all splicing occurs at a cryptic splice site 25 nucleotides 5Ј of the mutated wild-type site, resulting in an out-of-frame RESULTS message. In the presence of heterozygous sup-6 (st19), Identification of sup-39: Using single nucleotide polye309 cryptic splicing is altered. In addition to the Ϫ25 morphism mapping (Wicks et al. 2001) we localized cryptic splice site, there is significant splicing at the wildsup-39 to a 79,000-base region of LGII. We found a U1 type splice junction even though this splicing defines snRNA gene, 1 of 12 in the C. elegans genome, residing an intron beginning with an A, instead of the canonical in this interval, in the sixth intron of the gene C15F1.5.
G. This is consistent with a role for sup-6 in promoting We cloned and sequenced this U1 snRNA gene from splicing at the mutant splice donor. Two additional mistrains containing the two known sup-39 alleles, je5 and nor cryptic sites are also activated by st19 ( Figure 2C ). je6. An identical mutation, which changes the eighth sup-6 is a U1 snRNA gene: sup-6 maps to position nucleotide of this U1 snRNA gene from C to A, was 11.96 on LGII. One of the 12 C. elegans U1 snRNA genes found in the two sup-39 alleles ( Figure 1B ). This mutamaps to an interpolated position of 11.61 on LGII. This tion is a compensatory substitution that allows the 5Ј U1 snRNA gene resides in the fifth intron of the C. end of this U1 snRNA to base pair with a mutant 5Ј elegans gene F58G1.7 and has been annotated as F58-splice site containing a ϩ1G-to-U mutation ( Figure 1C ).
G1.10. We found that this U1 snRNA is mutated in sup-6 The ability of this U1 snRNA mutant to compensate for (st19) animals at the eighth position of the snRNA (Figthe mutation in the 5Ј splice site in unc-73(e936) provides ure 3A). This is the same position that is altered in the a logical explanation for how sup-39 mutants act as supsup-39 mutant U1. The mutation in st19 is complemenpressors. The suppressor U1 snRNA enhances the recogtary to the mutation in e309, allowing for proper base nition of the region of the overlapping Ϫ1 and wild-type pairing of the mutant U1 snRNA with the mutant 5Ј cryptic sites over the ϩ23 site. In both the uncsplice site ( Figure 3B ). This compensatory substitution 73(e936); sup-39(ϩ) and unc-73(e936);sup-39(je5) strains, in U1 snRNA promotes recognition of the mutant 5Ј the ratio of Ϫ1 and wild-type splice-site usage is 1:1. It splice site and activation of both steps of the splicing appears that at a subsequent step of spliceosome assemreaction, suppressing the aberrant splicing due to the bly, after U1 snRNP recognition, the Ϫ1 and wild-type e309 mutation. splice sites are chosen with equal efficiency. We made The C. elegans U1 snRNA genes: We have cataloged many attempts to suppress unc-73(e936) in animals by all of the U1 snRNA genes in C. elegans. The sequences expression of mutant sup-39 on a transgene. Even when of two different C. elegans U1 snRNA genes were initially diluted with carrier DNA, we were unable to generate reported by Thomas et al. (1990) . Using their initial transgenic lines containing extrachromosomal arrays sequences, we were able to use homology searches of expressing mutant sup-39. However, we could detect the completed genome to identify 12 different C. elegans co-injected GFP marker genes expressed in dying F 1 U1 snRNA genes. The C. elegans Wormbase Consortium embryos (data not shown). This result is consistent with (Harris et al. 2003) has provided annotations for only the lethality associated with sup-39, as 50% of homozy-6 of these 12. The alignment of the 12 U1 snRNAs is gous sup-39(je5) animals die as embryos (Run et al. 1996) .
shown in Figure 4 . The 5Ј ends of all of these U1 snRNAs, sup-6 also affects cryptic splice-site choice: Having the region that base pairs with the 5Ј splice site, are identified a U1 snRNA as a dominant suppressor of a identical. It may be coincidental, but of these 12 U1 ϩ1G mutation, we looked for other suppressors that act snRNA genes, only sup-39 and sup-6 reside in introns of in a similar fashion. sup-6(st19) is a dominant, alleleother genes. There is evidence for movement of C. elegspecific, extragenic suppressor of unc-13(e309). The e309 ans U1 snRNA genes within the genome during the allele contains a mutation in the first nucleotide of inperiod of divergence of C. elegans and C. briggsae. For tron 18, ϩ1G to A (Kohn et al. 2000 ; Figure 2A ). sup-6 example, while sup-39 resides in the sixth intron of (st19) was identified in screens for suppressors of unc-C15F1.5 in C. elegans, the C. briggsae homolog of C15F1.5 13(e309) as a suppressor of the uncoordination defect does not contain a U1 snRNA gene in its intron (data of e309. We have found that homozygous st19 animals not shown). sup-6 resides in the fifth intron of the C. undergo a late-larval developmental arrest. All of the elegans gene F58G1.7. The C. briggsae homolog of this embryos hatch, but larval development is dramatically gene also contains a U1 snRNA gene at the same posislowed and very few animals reach adulthood. Those tion. However, this C. briggsae homolog is a U1 snRNA pseudogene because it contains a deletion of nucleothat reach adulthood produce fewer than five viable et al. (2000) . (B) Predicted secondary structure of the sup-39 U1 snRNA based on the initial secondary structure prediction of C. elegans U1 snRNA genes by Thomas et al. (1990) . The site of the mutation in je5 and je6 is indicated. (C) Demonstration of the base pairing of the 5Ј end of U1 snRNA (identical in all 12 C. elegans U1 snRNA genes) with the 5Ј splice site of unc-73 intron 15. Below that is a demonstration that the mutation in the sup-39(je5) and (je6) alleles acts as a compensatory substitution for the unc-73(e936) mutation, which maintains U1 snRNA base pairing with the splice donor of intron 15. The changed nucleotides in both genes are boxed.
tides 78-110 of the U1 snRNA and thus could not be single base in a U1 snRNA gene. Second, the U1 snRNA functional. We could find evidence for 10 full-length C.
mutations themselves have deleterious consequences, briggsae U1snRNA genes (data not shown).
likely due to activation of aberrant splicing at additional genes. The sup-39 and sup-6 U1 snRNA mutations cause pleiotropic defects in development: 50% of homozygous DISCUSSION sup-39(je5) mutant animals die as embryos (Run et al. 1996) and sup-6(st19) homozygous animals undergo deWe have presented evidence that altered U1 snRNAs layed larval development leading to a late-larval arrest. can suppress the effects of mutations to the ϩ1G of Outside of the dominant suppression of e309, st19/ϩ introns. Recovery of such compensatory mutations as animals appear to have no obvious phenotype due to suppressors is likely to be very rare for two reasons. First, the mutagenic target in a forward genetic screen is a the sup-6 mutation. This difference between the pheno-in certain contexts are capable of suppression by this mechanism. Our results suggest the possibility that human diseases due to aberrant splicing at ϩ1G mutations may be treatable with suppressor U1 snRNAs. Previous studies using reverse genetics have identified U1 snRNA mutations able to activate alternative splice donors in metazoans in vivo (in tissue-culture cells and in flies) (Zhuang and Weiner 1986; Zhuang et al. 1987; Lo et al. 1994 ). These reverse-genetics studies examined compensatory substitutions in U1 snRNAs only at the Ϫ1, ϩ3, ϩ5, and ϩ6 positions of the 5Ј splice site, which vary naturally among splice donors in metazoans. Other studies in yeast and mammalian cells that looked specifically at mutations to the ϩ1 position of the intron had suggested that mutations to the first nucleotide of an intron could not be suppressed by compensatory mutations in U1 snRNA (Siliciano and Guthrie 1988; Cohen et al. 1994) . In some cases, the first step of splicing could be detected but these were dead-end products, indicating that the G at the first nucleotide of an intron is essential for the second step of splicing (Newman et al. 1985; Parker and Guthrie 1985; Newman and Norman 1991) . In another case, suppressor U1 snRNAs caused activation of nearby cryptic splice sites, not splicing at the original splice site (Cohen et al. 1994) . From these studies, it appears that the ϩ1G is important for other essential processes in splicing in addition to recognition by U1 snRNA.
The ϩ1 position of the intron is known to interact with the U5 snRNP protein PRP8 and with U6 snRNA at an early step in spliceosome assembly (Reyes et al. 1999; Maroney et al. 2000) . In addition, it may have this sort of suppression was unable to be accomplished previously by reverse-genetics approaches may be related to the lethality of these mutant U1 snRNAs that we observed in C. elegans. Transient transfection studies types of heterozygous vs. homozygous sup-6 mutants may have led to expression of the U1 snRNA transgenes indicates that there is a fine balance between the toxic containing compensatory mutations at too high a level, effects of the mutant U1 snRNA and suppression. That leading to toxicity. these U1 mutations do not cause more widespread deOne of the interesting questions that arises from this fects may reflect redundancy among the set of 12 U1 work is whether all U1 snRNA genes are expressed equivsnRNA genes in C. elegans; in addition, sup-6 or sup-39 alently and have equal function. Two independent isomay be expressed at lower levels or only in specific lates of extragenic suppressors of unc-73(e936) were both tissues. The extent to which the sup-6 and sup-39 mutafound in the sup-39 gene (Run et al. 1996) , and we have tions act as general suppressors of similar ϩ1G mutafound that these two alleles contain identical lesions. If all of the U1 snRNAs are expressed equivalently, then tions is unclear; it is possible that only ϩ1G mutations Demonstration of the base pairing of the 5Ј end of U1 snRNA with the 5Ј splice site of unc-13 intron 18. Below that is a demonstration that the mutation in the sup-6(st19) acts as a compensatory substitution for the unc-13(e309) mutation to maintain U1 snRNA base pairing with the splice donor of intron 18. The changed nucleotides in both genes are boxed. the odds of finding two rare U1 snRNA suppressors in disrupted in 15% of inherited genetic human diseases caused by point mutation (Stenson et al. 2003) . Of the same U1 snRNA gene would be 1 in 12. We do know that sup-39 is expressed in multiple tissues because in the disease-causing point mutations that disrupt splicing consensus sequences, the most common disruptions aladdition to its ability to alter unc-73(e936) cryptic splicing in neurons, we know from our previous study using ter the canonical G at the ϩ1 position of the intron, consistent with the essential nature of this G for proper splicing reporter transgenes that sup-39(je5) can suppress cryptic splicing in body-wall muscle cells (Roller splicing (Krawczak et al. 1992) . Our discovery of U1 snRNA mutants in C. elegans that suppress ϩ1G mutaet al. 2000). Perhaps sup-39 is expressed at much lower levels than the other U1 snRNA genes, and therefore tions by causing splicing at the wild-type site is suggestive of a method to repair this type of frequently occurring mutations in this gene can be tolerated because the toxicity will not be as high. There is evidence for develdisruption through the use of suppressor U1 snRNAs. However, no previous attempts to suppress ϩ1G mutaopmental stage-specific expression of U1 snRNA genes in Drosophila and in Xenopus (Forbes et al. 1984 ; Lo tions with suppressor U1 snRNAs in yeast, Drosophila, and mammalian tissue-culture cells have succeeded. and Mount 1990). It will be interesting in the future to determine whether developmental stage or tissue Our demonstration that this suppression can indeed work in C. elegans, along with our demonstration of the specificity is involved in the expression of the 12 C. elegans U1 snRNA genes. toxicity of these specific U1 snRNA suppressors, suggests a new hope that this type of suppression may work in It is estimated that splicing consensus sequences are U1 snRNA Suppressors in C. elegans -Sequence alignment of all 12 C. elegans U1 snRNA genes. Multiple alignments were determined using ClustalW (Thompson et al. 1994 ). Cosmid names are followed by a period and a number (for example, F08H9.10) if the U1 snRNA has been assigned a name by the C. elegans genome consortium. If the gene was not annotated, the name of the cosmid on which it is found is shown. If multiple, unannotated genes appear on the same cosmid, then the cosmid name is followed by a letter to distinguish the genes (for example, T27-E4.a). the ability of sup-6 and sup-39 to function in suppression.
681-689.
Because wild-type C. elegans introns begin with G, any
